Search This Blog

Tuesday, March 31, 2020

FDA OKs emergency use of Qiagen coronavirus test

The FDA grants Emergency Use Authorization for QIAGEN’s (NYSE:QGEN) QIAstat-Dx Respiratory SARS-CoV-2 Panel test for use in diagnosing COVID-19 infection. The test can differentiate the SARS-CoV-2 viral infection from 21 other serious respiratory infections in about an hour from nasopharyngeal swabs.
Related ticker: Thermo Fisher Scientific (NYSE:TMO)
https://seekingalpha.com/news/3556638-fda-oks-emergency-use-of-qiagen-coronavirus-test

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.